Utah Medical Products (NASDAQ:UTMD - Get Free Report) announced its earnings results on Tuesday. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter, Zacks reports. Utah Medical Products had a return on equity of 12.10% and a net margin of 34.62%.
Utah Medical Products Price Performance
Shares of Utah Medical Products stock traded down $1.17 during trading hours on Tuesday, hitting $63.00. 31,829 shares of the company's stock traded hands, compared to its average volume of 21,584. The company has a fifty day simple moving average of $62.82 and a 200-day simple moving average of $65.62. Utah Medical Products has a 12-month low of $60.08 and a 12-month high of $83.05. The stock has a market capitalization of $213.57 million, a price-to-earnings ratio of 14.75 and a beta of 0.09.
Utah Medical Products Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, January 3rd. Stockholders of record on Monday, December 16th were given a dividend of $0.305 per share. The ex-dividend date was Monday, December 16th. This is a positive change from Utah Medical Products's previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 1.94%. Utah Medical Products's dividend payout ratio (DPR) is currently 28.57%.
Analyst Ratings Changes
Separately, StockNews.com lowered Utah Medical Products from a "strong-buy" rating to a "buy" rating in a research report on Thursday, November 7th.
View Our Latest Analysis on UTMD
About Utah Medical Products
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Read More
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
